Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer
NCT04820179
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Metastatic Pancreatic Cancer
Interventions
DRUG:
Cabozantinib + Atezolizumab
Sponsor
University of Arizona